ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 27 of 1289 for:    physician patient AND (relations OR communication) | Recruiting, Not yet recruiting, Available Studies

Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03300284
Recruitment Status : Recruiting
First Posted : October 3, 2017
Last Update Posted : February 27, 2018
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.

Condition or disease Intervention/treatment
Thyroid Cancer Behavioral: Questionnaires

Study Type : Observational
Estimated Enrollment : 120 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
Actual Study Start Date : August 7, 2017
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : August 2020

Resource links provided by the National Library of Medicine

Drug Information available for: Thyroid

Group/Cohort Intervention/treatment
Thyroid cancer
This study does not involve any intervention, but rather data collection on patient and physician preferences and beliefs, communication, and patient psychological outcomes.
Behavioral: Questionnaires
Quality of Life Questionnaires




Primary Outcome Measures :
  1. influencing decision making pre-visit [ Time Frame: 3 years ]
    Patients will complete a pre-visit questionnaire and the patient-physician interaction during the visit will be recorded and subjected to qualitative analysis for extraction of variables representing the presence of elements of shared decision making and strength of physician influence.

  2. influencing decision making post-visit [ Time Frame: 3 years ]
    Patients will complete a post-visit questionnaire, and the patient-physician interaction during the visit will be recorded and subjected to qualitative analysis for extraction of variables representing the presence of elements of shared decision making and strength of physician influence.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study will be conducted primarily in the MSK endocrinology and surgery clinics, which have a large volume of patients with LR-PTC choosing both surgery and AS. We also expect to expand this study to several clinics within the MSK Alliance Network and outside participating sites.
Criteria

Inclusion Criteria:

  • Able to read, write, and communicate in English Patients who have been diagnosed with LR-PTC as described above
  • For Aim 1, adults with recently diagnosed LR-PTC who have not yet made a choice between surgery and AS
  • For Aim 2, adults with LR-PTC who made a decision about surgery or AS at least 3 months prior, but no more than 4 years prior to their routine follow-up visit at which they are being recruited for this study.
  • Active patients of MSK and participating institutions

Exclusion Criteria:

  • Patients who have been diagnosed with a tumor greater than 2 cm
  • Patients with clinically suspicious lymphadenopathy in the neck
  • Patients with evidence of gross ETE after a biopsy of the papillary thyroid tumor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03300284


Contacts
Contact: Benjamin Roman, MD, MSHP 212-639-7799 romanb@mskcc.org
Contact: Jennifer Hay, PhD 646-888-0039

Locations
United States, New York
NYU Langone Health Not yet recruiting
New York, New York, United States, 10010
Contact: Jennifer Ogilvie, MD    212-263-7710      
Mount Sinai Hospital Not yet recruiting
New York, New York, United States, 10029
Contact: Mark Urken, MD    212-844-8775      
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Benjamin Roman, MD, MSHP    212-639-7799      
Contact: Jennifer Hay, PhD    646-888-0039      
Principal Investigator: Benjamin Roman, MD, MSHP         
United States, Pennsylvania
Lehigh Valley Health Network Not yet recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Heiwon Chung, MD    610-402-7884      
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Principal Investigator: Benjamin Roman, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT03300284     History of Changes
Other Study ID Numbers: 17-382
First Posted: October 3, 2017    Key Record Dates
Last Update Posted: February 27, 2018
Last Verified: November 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Memorial Sloan Kettering Cancer Center:
Quality of Life
Decision Making
17-382

Additional relevant MeSH terms:
Thyroid Diseases
Thyroid Neoplasms
Carcinoma
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type